Latest Blogs

Feb 14, 2018
Patient advocate Ms. Carole Seigel discusses ASCO's new clinical practice guideline on managing immune-related adverse events for patients treated with checkpoint inhibitors.  
Feb 13, 2018
A recent event brought home the significance of how devastating news is received and how we react to a potentially life-changing message.
Feb 05, 2018
Almost every day a patient (and often many more than one) asks Dr. Evan Hall, “How will my cancer diagnosis affect my life?” This is a difficult question to answer. 
Feb 01, 2018
"Can we increase the chances to make early diagnoses in patients with cancer? Yes, we can, I can, but how?" asks Dr. Jose Angel Sanchez.
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

Jul 22, 2014
The use of statins to control dyslipidemia is now over 20 years old and supported for patients with coronary artery disease by the landmark Scandanavian Simvastatin Survival Study published in 1994....
Jun 02, 2014
Adding 6 cycles of docetaxel at the outset of hormonal therapy for prostate cancer has been shown to improve survival, especially in men with a high burden of disease. The much-...
Apr 18, 2014
So how did the robot take over? As I recall, it started with "hospital A" buying the fancy robot for their urologists to use, after said urologists insisted that this was the way of the future. The Intuitive Surgical Company did an...
Mar 10, 2014
A new article appeared this week with further fuel for those on the side of intervention (and by implication, pro-screening). Let's remember before we get started that the two...
Feb 07, 2014
Long, long ago, I had just finished my fellowship in medical oncology and moved from Boston to Denver. In the lab, I was working on an obscure enzyme that seemed to differentiate leukemia from normal cells,cystathionase. In...
Jan 15, 2014
These two questions are among the most commonly asked in my clinic, particularly from patients who are recently diagnosed with prostate cancer.

Pages